Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells

British Journal of Cancer

Volumn 81, Issue 8, 1999, Pages 1344-1350

  Pimpec Barthes, F Le ^a   Bernard, I ^b   Alsamad I, Abd ^c   Renier, A ^d   Kheuang, L ^d   Fleury Feith, J ^e   Devauchelle, P ^b   Colonna, F Quintin ^b   Riquet, M ^a   Jaurand, M C ^d  

^a Hopital Laennec   (France)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d INSERM   (France)

^e HÔPITAL TENON   (France)

Author keywords

Culture; Malignant mesothelioma; Nude rats; Transplantation

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BODY WEIGHT; CANCER CELL; CANCER TRANSPLANTATION; CONTROLLED STUDY; DIAPHRAGM; HISTOLOGY; HUMAN CELL; LUNG CARCINOGENESIS; MALIGNANT MESOTHELIOMA; MEDIASTINUM; MORPHOLOGY; NONHUMAN; PERICARDIUM; PLEURA CAVITY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; RAT; THORAX RADIOGRAPHY; TUMOR LOCALIZATION;

EID: 0032711347     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6693248     Document Type: Article

References (20)

1. Astoul P, Viallat JR, Laurent JC, Brandely M and Boutin C (1993) Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion. Chest 103: 209-213
2. Baselga J and Mendelsohn J (1994) The epidermal growth factor receptor as a target for therapy in breast cancer. Breast Cancer Res Treat 29: 127-138
3. Bishop JF (1995) Scheduling of chemotherapy in locally advanced non-small-cell lung cancer. Lung Cancer 12: S53-S61
4. Carbone M, Rizzo P and Pass HI (1997) Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15: 1877-1888
5. Chahinian AP, Kirschner PA, Gordon RE, Szrajer L and Holland JF (1991) Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison. Cancer 68: 558-560
6. Corson JM (1986) Pathology of malignant mesothelioma. In: Asbestos Related Malignancy. Antman K and Aisner J (eds), pp. 179-199. Harcourt Brace Jovanovich: New York
7. Davis BM, Koc ON, Lee K and Gerson SL (1996) Current progress in the gene therapy of cancer. Curr Opin Oncol 8: 499-508
8. Esandi MC, van Someren GD, Vincent AJPE, van Bekkum DW, Valerio D and Bout A (1997) Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene. Gene Ther 4: 280-287
9. Fleury-Feith J, Nebut M, Saint Etienne L, Laurent P, Pinchon MC, Kheuang L, Renier A and Jaurand MC (1989) Occurrence and morphology of tumors induced in nude mice transplanted with chrysotile-transformed rat pleural mosothelial cells. Biol Cell 65: 45-50
10. Gutman M and Fidler IJ (1995) Biology of cancer colon metastasis. World J Surg 19: 226-234
11. Hoogsteden HC, Langerak AW, van der Kwast TH, Versnel MA and van Gelder T (1997) Malignant pleural mesothelioma. Crit Rev Oncol Hematol 25: 92-126
12. Hwang HC, Smythe WR, Elshami AA, Kucharezuk JC, Amin KM, Williams JP, Litzky LA, Kaiser LA and Albelda SM (1995) Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol 13: 7-16
13. Jaurand MC, Fleury J, Monchaux G, Nebut M and Bignon J (1987) Pleural carcinogenic potency of mineral fibers (asbestos, attapulgite) and their cytotoxicity on cultured cells. J Natl Cancer Inst 79: 797-804
14. Monchaux G, Bignon J, Jaurand MC, Lafuma J, Sebastien P, Masse R, Hirsch A and Goni J (1981) Mesothelioma in rats following inoculation with acid-leached chrysotile asbestos and other mineral fibres. Carcinogenesis 2: 229-236
15. Perrin D, Halazy S and Hill B (1997) Inhibitors of ras farnesylation: tomorrow's anticancer agents? Bull Cancer 84: 635-642
16. Ross G, Erickson R, Knorr D, Motulsky AG, Parkman R, Samulski J, Strauss SE and Smith BR (1996) Gene therapy in the United States: a five-year status report. Hum Gene Ther 7: 1781-1790
17. Smythe WR, Kaiser LR, Hwang HC, Amin KM, Pilewski JM, Eck SJ, Wilson JM and Albelda SM (1994) Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg 57: 1395-1401
18. Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K, Recio A, Knox L, Wilson JM, Albelda SM and Kaiser LR (1998) Adenovirus-mediated herpes simplex virus thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 9: 1083-1092
19. Togo S, Shimada H, Kubota T, Moossa AR and Hoffman RM (1995) Host organ specifically determines cancer progression. Cancer Res 55: 681-684
20. Zeng L, Fleury-Feith J, Monnet I, Boutin C, Bignon J and Jaurand MC (1994) Immunocytochemical characterization of cell lines from human malignant mesothelioma; characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies. Hum Pathol 25: 227-234